Phase III Study Comparing Maintenance With Pemetrexed or Gemcitabine to a Surveillance in Elderly Patients (70 Years Old and More) With a Advanced Non Small Cell Lung Cancer Controlled by Induction Chemotherapy.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 01 Mar 2019
At a glance
- Drugs Gemcitabine (Primary) ; Pemetrexed (Primary) ; Carboplatin; Erlotinib; Paclitaxel
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms MODEL
- 25 Feb 2019 Planned End Date changed from 1 Dec 2018 to 1 Jul 2020.
- 25 Feb 2019 Planned primary completion date changed from 1 Sep 2018 to 1 Jun 2019.
- 24 Apr 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Sep 2018.